Stanford University
Showing 13,481-13,500 of 36,182 Results
-
Michaela Hulstyn
SLE Associate Director
BioMichaela Hulstyn is the Associate Director of Structured Liberal Education (SLE), a first-year residential education program at Stanford University.
She is the author of Unselfing: Global French Literature at the Limits of Consciousness (University of Toronto Press, 2022.) Her research interests center on 20th- and 21st-century French and Francophone literature, phenomenology of the self and intersubjectivity, cognitive approaches to transcultural literature, and literature as ethical philosophy. Her work has appeared in MLN, Philosophy and Literature, and Contemporary French and Francophone Studies, among other places.
Michaela previously held academic appointments at Florida State University and Reed College. -
Holmes Hummel, PhD
Managing Director Energy Equity & Just Transitions, Precourt Institute for Energy
Current Role at StanfordEnergy Equity & Just Transitions, Managing Director
Precourt Institute for Energy
Resident Fellow, Explore Energy House
Coordinating Council Member, Environmental Justice Working Group
Advisory Member, Partnership in Climate Justice in the Bay
Collaborator in Collaborative Learning about Equity and Rapid Decarbonization (CLEAR Decarbonization), one of the first projects selected for an award from the Stanford Sustainability Accelerator -
Keith Humphreys
Esther Ting Memorial Professor and Professor, by courtesy, of Health Policy
Current Research and Scholarly InterestsDr. Humphreys researches individual and societal level interventions for addictive and psychiatric disorders. He focuses particularly on evaluating the outcomes of professionally-administered treatments and peer-operated self-help groups (e.g., Alcoholics Anonymous), and, analyzing the impact of public policies touching addiction, mental health, public health, and public safety.
-
Paul S Humphries
Alliance Director, Innovative Medicines Accelerator (IMA)
Current Role at StanfordAlliance Director, Stanford Innovative Medicines Accelerator (IMA)
